BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26909566)

  • 1. BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma.
    Wang Y; Guo Z; Shu Y; Zhou H; Wang H; Zhang W
    Eur J Cancer Prev; 2017 Mar; 26(2):144-150. PubMed ID: 26909566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathological roles of BART miRNAs in nasopharyngeal carcinoma.
    Lo AK; Dawson CW; Jin DY; Lo KW
    J Pathol; 2012 Aug; 227(4):392-403. PubMed ID: 22431062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
    Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
    Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BART-D2 subtype of EBV encoded BART miRNA cluster 1 region is strongly associated with endemic nasopharyngeal carcinoma.
    Wang Q; He H; Ji X; Liu Y; Li H; Wang Y
    J Med Virol; 2023 Mar; 95(3):e28667. PubMed ID: 36912378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.
    Cai L; Ye Y; Jiang Q; Chen Y; Lyu X; Li J; Wang S; Liu T; Cai H; Yao K; Li JL; Li X
    Nat Commun; 2015 Jul; 6():7353. PubMed ID: 26135619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of EBV-encoded BART-miRNAs and dysregulated cellular miRNAs in nasopharyngeal carcinoma genesis.
    Xie YJ; Long ZF; He XS
    Asian Pac J Cancer Prev; 2013; 14(10):5637-44. PubMed ID: 24289555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
    Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of microRNAs in nasopharyngeal carcinoma.
    Tan G; Tang X; Tang F
    Tumour Biol; 2015 Jan; 36(1):69-79. PubMed ID: 25427638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
    Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas.
    Zeng Z; Huang H; Huang L; Sun M; Yan Q; Song Y; Wei F; Bo H; Gong Z; Zeng Y; Li Q; Zhang W; Li X; Xiang B; Li X; Li Y; Xiong W; Li G
    Sci China Life Sci; 2014 Mar; 57(3):315-326. PubMed ID: 24532457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-encoded microRNA BART22 serves as novel biomarkers and drives malignant transformation of nasopharyngeal carcinoma.
    Zhang T; Chen Z; Deng J; Xu K; Che D; Lin J; Jiang P; Gu X; Xu B
    Cell Death Dis; 2022 Jul; 13(7):664. PubMed ID: 35907914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review.
    Lee KT; Tan JK; Lam AK; Gan SY
    Crit Rev Oncol Hematol; 2016 Jul; 103():1-9. PubMed ID: 27179594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
    Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
    Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV-encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1.
    Lung RW; Tong JH; Ip LM; Lam KH; Chan AW; Chak WP; Chung LY; Yeung WW; Hau PM; Chau SL; Tsao SW; Lau KM; Lo KW; To KF
    J Cell Mol Med; 2020 Nov; 24(22):13523-13535. PubMed ID: 33074587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustered microRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor.
    Kanda T; Miyata M; Kano M; Kondo S; Yoshizaki T; Iizasa H
    J Virol; 2015 Mar; 89(5):2684-97. PubMed ID: 25520514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.